Biomarin Pharmaceutical (BMRN) Gross Margin Growth (3y) (2012 - 2026)
Biomarin Pharmaceutical (BMRN) Gross Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 722.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -191.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -162.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -40.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Biomarin Pharmaceutical | 11.33 Bn | 9.11 Bn | 571.21 Mn | -274.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -274.00 |
| Dec 31, 2025 | -424.00 |
| Sep 30, 2025 | 496.00 |
| Jun 30, 2025 | 488.00 |
| Mar 31, 2025 | 218.00 |
| Dec 31, 2024 | 841.00 |
| Sep 30, 2024 | 6.00 |
| Jun 30, 2024 | 700.00 |
| Mar 31, 2024 | 543.00 |
| Dec 31, 2023 | 655.00 |
| Sep 30, 2023 | 1,757.00 |
| Jun 30, 2023 | 87.00 |
| Mar 31, 2023 | -53.00 |
| Dec 31, 2022 | -618.00 |
| Sep 30, 2022 | -199.00 |
| Jun 30, 2022 | -310.00 |
| Mar 31, 2022 | -27.00 |
| Dec 31, 2021 | -538.00 |
| Sep 30, 2021 | -519.00 |
| Jun 30, 2021 | -413.00 |